Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GAP
1901
PUT
The Gap Inc
GAP
$7.3B
| $17.4M | 0.01% |
454,800
+44,700
| +11% | +$1.77M |
|
|
INVN
1902
DELISTED
Invensense Inc
INVN
| $17.3M | 0.01% |
1,147,165
+342,937
| +43% | +$5.18M |
|
1903
First Trust Health Care AlphaDEX Fund
FXH
$1.05B
| $17.2M | 0.01% |
250,003
-138
| -0.1% | -$9.33K |
|
1904
Dine Brands
DIN
$462M
| $17.1M | 0.01% |
172,743
-168,568
| -49% | -$16.8M |
|
1905
Texas Roadhouse
TXRH
$13.7B
| $17.1M | 0.01% |
455,722
+75,515
| +20% | +$2.7M |
|
|
CLNY
1906
DELISTED
Colony Capital, Inc.
CLNY
| $17M | 0.01% |
752,438
-678,251
| -47% | -$17.2M |
|
1907
PUT
Avis
CAR
$5.47B
| $17M | 0.01% |
386,300
+258,000
| +201% | +$13.6M |
|
1908
ICICI Bank
IBN
$107B
| $17M | 0.01% |
1,796,385
-138,078
| -7% | -$1.3M |
|
1909
CALL
General Mills
GIS
$20.2B
| $17M | 0.01% |
304,600
-170,800
| -36% | -$9.57M |
|
|
FOLD
1910
DELISTED
Amicus Therapeutics
FOLD
| $17M | 0.01% |
1,198,149
-303,284
| -20% | -$3.65M |
|
1911
Green Plains
GPRE
$1.15B
| $16.9M | 0.01% |
614,959
+126,202
| +26% | +$3.88M |
|
1912
Realty Income
O
$61.1B
| $16.9M | 0.01% |
393,512
-267,114
| -40% | -$12.2M |
|
|
WBK
1913
DELISTED
Westpac Banking Corporation
WBK
| $16.9M | 0.01% |
681,501
+6,412
| +0.9% | +$174K |
|
1914
iShares Preferred and Income Securities ETF
PFF
$13.1B
| $16.9M | 0.01% |
430,285
+125,912
| +41% | +$4.99M |
|
1915
Telefônica Brasil
VIV
$20.4B
| $16.8M | 0.01% |
1,208,653
-725,781
| -38% | -$10.8M |
|
|
ALDR
1916
DELISTED
Alder Biopharmaceuticals
ALDR
| $16.8M | 0.01% |
317,373
-57,322
| -15% | -$2.08M |
|
|
TW
1917
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $16.8M | 0.01% |
133,336
+48,425
| +57% | +$6.5M |
|
|
DST
1918
DELISTED
DST Systems Inc.
DST
| $16.7M | 0.01% |
265,300
+118,892
| +81% | +$7.05M |
|
1919
AeroVironment
AVAV
$7.19B
| $16.7M | 0.01% |
639,453
-11,760
| -2% | -$310K |
|
1920
Align Technology
ALGN
$12.9B
| $16.7M | 0.01% |
265,904
+201,598
| +313% | +$11.9M |
|
1921
PUT
Stratasys
SSYS
$666M
| $16.7M | 0.01% |
477,300
+191,400
| +67% | +$8.03M |
|
|
MPT
1922
Medical Properties Trust
MPT
$2.84B
| $16.7M | 0.01% |
1,270,392
-41,828
| -3% | -$583K |
|
1923
PUT
Emerson Electric
EMR
$81.6B
| $16.6M | 0.01% |
300,200
-163,000
| -35% | -$9.58M |
|
1924
CALL
iShares MSCI Taiwan ETF
EWT
$9.13B
| $16.6M | 0.01% |
525,850
-16,600
| -3% | -$535K |
|
|
TGP
1925
DELISTED
Teekay LNG Partners L.P.
TGP
| $16.6M | 0.01% |
514,886
-137,328
| -21% | -$4.96M |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.